Chronic Disease Management Market Size, Share & Trends Analysis Report By Offerings (Solutions, Services), By Delivery Mode (On-premise, Cloud-based), By Disease Indication (Diabetes, Cardiovascular Diseases, Respiratory Diseases, Cancer, Chronic Kidney Disease (CKD), Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Chronic Disease Management Market Size

The global chronic disease management market size was valued at USD 6.28 billion in 2025 and is projected to grow from USD 7.08 billion in 2026 to USD 18.57 billion by 2034, registering a CAGR of 12.8% during the forecast period from 2026 to 2034. North America dominated the chronic disease management market with a market share of 38.4% in 2025.

Chronic disease management refers to the comprehensive approach used to monitor, treat, and improve the quality of life for individuals with long-term health conditions, such as cardiovascular diseases, respiratory disorders, and arthritis. It involves the use of preventive care, personalized treatment plans, regular monitoring, and patient education to reduce disease progression, minimize complications, and lower healthcare costs. This approach often incorporates digital health tools like telemedicine, remote monitoring, and mobile health apps to enhance patient engagement and facilitate continuous care.

The rising prevalence of chronic conditions such as cardiovascular diseases, respiratory disorders, and arthritis is a key driver of the market. These conditions require ongoing care, regular monitoring, and personalized management plans to prevent complications and improve patient outcomes. As the number of individuals with chronic diseases increases, healthcare providers are turning to advanced solutions such as remote monitoring, telemedicine, and digital health platforms to manage these conditions more effectively.

This continuous need for care creates a sustained demand for innovative tools that can enhance patient engagement, provide real-time data, and support proactive interventions, ultimately helping to improve the overall management of chronic diseases.

Chronic Disease Management Market Growth Factors

Rising Prevalence of Chronic Diseases

The rising prevalence of chronic diseases is a major driver in the global market. As conditions such as diabetes, cardiovascular disease, and chronic respiratory disorders become more common, there is an increasing demand for effective management solutions. This growing patient population necessitates advanced tools and programs to manage and monitor these diseases, leading to greater adoption of digital health technologies, comprehensive care models, and preventive strategies.

• For instance, the America’s Health Rankings 2023 Annual Report revealed that diabetes affects 11.5% of adults, impacting nearly 31.9 million individuals. Additionally, chronic conditions like Chronic Obstructive Pulmonary Disease (COPD) and cancer showed significant disparities among different ethnic groups, with American Indian/Alaska Native adults experiencing COPD at rates 7.1 times higher than Asian adults, and American adults having cancer rates 3.9 times higher than Asian adults.

The rising prevalence of chronic diseases is driving demand for innovative management solutions, pushing the adoption of advanced digital health technologies and comprehensive care models.

Increased Focus on Preventive Care

The growing emphasis on preventive care is a significant driver in the market. Healthcare systems are shifting from reactive treatment to proactive disease prevention, aiming to reduce the long-term burden of chronic conditions like diabetes, cardiovascular disease, and respiratory disorders. Preventive care strategies include early diagnosis, regular monitoring, lifestyle interventions, and patient education, which not only improve health outcomes but also lower healthcare costs.

• For instance, in February 2024, Henry Schein, Inc. launched the "Prevention is Power" campaign through the Henry Schein Cares Foundation. This initiative aims to enhance health literacy and promote the use of preventive care, with the goal of reducing chronic disease incidence and overall healthcare spending. This emphasis on prevention not only supports better health outcomes but also boosts the demand for comprehensive chronic disease management solutions.

Restraining Factor

Data Privacy and Security Concerns

As digital health technologies play an increasingly central role in chronic disease management, concerns over data privacy and security have become major restraining factors. The collection, storage, and transmission of sensitive health information through electronic systems expose patient data to potential breaches and unauthorized access. Such vulnerabilities can lead to severe legal and financial consequences, including fines and loss of patient trust, making healthcare organizations more hesitant to adopt digital management solutions.

• For example, in August 2023, the Office for Civil Rights (OCR) reported 725 data breaches, affecting over 133 million patient records. These incidents not only compromise privacy but also impose significant legal and financial burdens on healthcare providers, further complicating the widespread adoption of digital tools for managing chronic diseases. Safeguarding data is critical to ensuring the future success of digital health initiatives in this sector.

Market Opportunity

Shift to Value-Based Care in Chronic Disease Management

The global market is increasingly shifting towards value-based care, which prioritizes patient outcomes over the quantity of services provided. This approach focuses on preventive care, personalized treatment plans, and long-term management strategies, all aimed at improving care quality, reducing hospital readmissions, and lowering healthcare costs. By emphasizing outcome-based care, healthcare providers can offer more targeted and efficient chronic disease management.

• For instance, in July 2022, Physicians Office Resource highlighted the benefits of value-based care for primary care physicians managing chronic conditions like diabetes and chronic kidney disease (CKD). This model allows physicians to concentrate more on patient outcomes, leading to enhanced care quality. A survey by the American Academy of Family Physicians and CompHealth found that 87% of providers value closer patient interaction under this model. The shift supports the Quadruple Aim improving patient outcomes, lowering costs, and enhancing both patient and clinician experiences.

This transition to value-based care is a significant market trend, poised to transform chronic disease management by fostering better outcomes, higher patient satisfaction, and reduced healthcare expenses.

Segmentation Analysis

By Offerings

The global market is bifurcated into solutions and services. The solutions segment currently dominates, encompassing software and hardware tools such as remote monitoring systems, mobile health applications, and wearable devices. These solutions are increasingly popular due to their role in enhancing patient monitoring, improving data accuracy, and enabling proactive management of chronic conditions.

• For instance, in August 2024, Fitbit expanded its health tracking features to include AI-driven insights for chronic disease management, enhancing the predictive capabilities and personalized care options available to patients.

Request Customizationto receive a tailored report.

By Delivery Mode

The global market is divided into on-premise and cloud-based. Cloud-based solutions lead due to their flexibility, scalability, and ease of access. These solutions allow healthcare providers to efficiently manage patient data and integrate various tools. For example, Taiwan-based Health2Sync's cloud-based program enhances personalized chronic disease management by capturing continuous glucose monitoring (CGM) data through its mobile app. Recently, Health2Sync announced plans to commercialize digital therapeutics (DTx) for insulin management with Sanofi. This illustrates how cloud-based systems are driving innovation and improving patient care in the chronic disease management sector.

By Disease Type

The global market is categorized into diabetes, cardiovascular diseases, respiratory diseases, cancer, chronic kidney disease (CKD), and others. Cardiovascular diseases (CVD) are the dominant segment because they are widespread and require continuous management to prevent severe complications. This high demand for care services and monitoring tools reflects the critical need for effective management strategies.

• For instance, in February 2023, Dawn Health, a digital health company based in Copenhagen, partnered with the pharmaceutical giant Novartis to develop a new chronic condition management platform. Their collaboration focuses on creating remote monitoring and management tools for various chronic conditions, including CVD, hypertension, and breast cancer.

Speak to an Analystto discuss market opportunities.

Regional Insights

North America: Dominant Region with 44.2% Market Share

In North America, particularly the U.S., telehealth and mHealth solutions are central to chronic disease management. High smartphone and wearable device usage allows patients to manage conditions like diabetes and heart disease from home, with apps and Bluetooth devices enabling remote monitoring and data collection. This approach is vital for the nearly 50% of Americans with multiple chronic illnesses and has been further emphasized by the COVID-19 pandemic, which highlighted the need for virtual care. As wearable technology evolves, integrating telehealth and mHealth remains key to addressing the chronic disease burden.

Unlock Regional Insightsto access country-level data, & regional trends.

Asia-Pacific: Fastest Growing Region

In the Asia-Pacific market, government initiatives are playing a pivotal role in advancing chronic disease management through increased healthcare spending, supportive regulations, and widespread public awareness campaigns. These initiatives aim to improve early detection, treatment, and long-term management of chronic conditions. Moreover, emerging business models like pay-for-performance, which incentivizes healthcare providers based on patient outcomes, are enhancing care quality and efficiency.

Countrywise Insights

The chronic disease management market is experiencing dynamic growth and diversification across the globe, with each country contributing uniquely to the advancement of this transformative field. Below are a few countries that illustrate the diverse contributions and advancements in chronic disease management.

• United States- The U.S. leads the chronic disease management industry due to its advanced healthcare infrastructure and high prevalence of chronic conditions like diabetes and cardiovascular diseases. The market benefits from the widespread adoption of digital health technologies and value-based care models. Recent data shows that 37.3 million Americans have diabetes, and about 50% of adults suffer from cardiovascular diseases. Innovations in telemedicine and wearable devices are driving market growth.
• Canada - Canada’s healthcare system is increasingly adopting digital health technologies to manage chronic diseases. The implementation of remote monitoring and telehealth services is growing, with about 35% of chronic disease patients utilizing these technologies. Recent developments include expanded telemedicine services across rural areas.
• Germany - Germany’s market is bolstered by its robust healthcare system and a strong focus on preventive care. In 2023, Germany invested over €10 billion in digital health solutions, aiming to improve the management of conditions like heart disease and COPD through comprehensive care models and advanced monitoring technologies.
• France - France is making strides in chronic disease management through its investment in digital health technologies and preventive care programs. The market is expanding with the adoption of telehealth and remote monitoring solutions. By 2023, around 10 million French citizens were managing chronic diseases, driven by national health strategies focusing on early intervention and patient self-management.
• India- India’s market for chronic disease management is rapidly growing due to increasing chronic disease prevalence and advancements in healthcare technology. In 2023, India’s healthcare spending on chronic diseases reached $45 billion, with a significant portion allocated to expanding telehealth and remote monitoring services for conditions like heart disease and COPD.
• China- China's chronic disease management market is expanding rapidly, driven by its large population and rising chronic disease rates, particularly in cardiovascular and respiratory diseases. In 2023, China’s healthcare expenditure on chronic disease management grew by 15%, reaching $73 billion, supported by government initiatives to enhance healthcare accessibility and technology adoption.
• Japan- Japan is advancing in the market, focusing on technology-driven solutions and remote patient monitoring. The country has introduced several innovative devices for managing respiratory diseases. For instance, the development of advanced wearable devices like the "AeroSmart" smart inhaler, which provides real-time monitoring and medication management for respiratory conditions, highlights the country's focus on technology-driven chronic disease management.

Company Market Share

Key market players are strategically investing in improving their digital infrastructure to meet the increasing demand. These players also focus on key business strategies, such as strategic collaborations, relevant acquisitions, and innovative partnerships, among others.

Eli Lilly and Company: An emerging player in this market

Eli Lilly and Company is a global pharmaceutical leader headquartered in Indianapolis, Indiana. Founded in 1876, the company is renowned for its innovative research and development in areas such as diabetes, oncology, immunology, and neuroscience. The company focuses on addressing complex medical challenges and improving patient outcomes through cutting-edge therapies and a robust pipeline of new medicines.

Recent developments at Eli Lilly and Company include:

• In 2024, Eli Lilly and Company, a pharmaceutical company, introduced LillyDirect, a new digital healthcare platform designed for patients in the U.S. for managing conditions such as obesity, migraine, and diabetes. LillyDirect provides disease management tools, personalized support, and the convenience of home delivery for certain Lilly medications through third-party pharmacy services.

List of Key and Emerging Players in Chronic Disease Management Market

• Philips Healthcare
• Medtronic
• Abbott
• IBM Watson Health
• GE Healthcare
• Roche Diagnostics
• Siemens Healthineers
• Dexcom
• Eli Lilly and Company
• Omron Healthcare
• Cerner Corporation
• Epic Systems Corporation
• Teladoc Health
• Allscripts Healthcare Solutions
• Fitbit
• Apple Inc.